Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.
Matthias HolzlechnerEliseo A EugeninBrendan PrideauxPublished in: Cancer reports (Hoboken, N.J.) (2021)
MSI offers a unique approach for biomolecular characterization of tumor tissues and provides valuable complementary information to histology for lipid biomarker discovery and tumor classification in clinical and research cancer applications.